Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9494
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rogiers, A. | - |
dc.contributor.author | Dimitriou, F. | - |
dc.contributor.author | Lobon, I. | - |
dc.contributor.author | Harvey, C. | - |
dc.contributor.author | Vergara, I. A. | - |
dc.contributor.author | Pires da Silva, Ines | - |
dc.contributor.author | Lo, S. N. | - |
dc.contributor.author | Scolyer, Richard A. | - |
dc.contributor.author | Carlino, Matteo S. | - |
dc.contributor.author | Menzies, A. M. | - |
dc.contributor.author | Long, G. V. | - |
dc.date.accessioned | 2024-04-23T04:29:54Z | - |
dc.date.available | 2024-04-23T04:29:54Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | European Journal of Cancer 198:113506, 2024 | - |
dc.identifier.uri | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9494 | - |
dc.description.abstract | BACKGROUND: Immune checkpoint inhibitors are frequently associated with the development of immunotherapy-related adverse events (irAEs). The exact etiology, including the role of environmental factors, remains incompletely understood. METHODS: We analyzed the records of 394 melanoma patients from three centers (northern and southern hemisphere). Patients had received at least one cycle of anti-PD-1/anti-CTLA-4 with a minimum follow-up of 3 months. We study the distribution and time to irAEs onset throughout the calendar year. RESULTS: 764 irAEs were recorded; the most frequent were skin rash (35%), hepatitis (32%) and colitis (30%). The irAEs incidence was the highest in autumn and winter, and the ratio for the 'number of irAEs' per 'therapies commenced' was the highest in winter and lowest in summer (2.4 and 1.7, respectively). Season-specific patterns in the time of irAEs onset were observed for pneumonitis (shorter time to onset in autumn, p = 0.025), hepatitis (shorter time to onset in spring, p = 0.016) and sarcoid-like immune reaction (shorter time to onset in autumn, p = 0.041). Season-specific patterns for early-onset irAEs were observed for hepatitis (spring, p = 0.023) and nephritis (summer, p = 0.017). Early-onset pneumonitis was more frequent in autumn-winter (p = 0.008) and early-onset nephritis in spring-summer (p = 0.004). CONCLUSIONS: Environmental factors that are associated with particular seasons may contribute to the development of certain irAEs and suggest the potential effect of environmental triggers. The identification of these factors may enhance preventive and therapeutic strategies to reduce the morbidity of irAEs. | - |
dc.subject | Oncology | - |
dc.title | Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy | - |
dc.type | Journal Article | - |
dc.identifier.doi | https://dx.doi.org/10.1016/j.ejca.2023.113506 | - |
dc.subject.keywords | antibodies, monoclonal | - |
dc.subject.keywords | hepatitis | - |
dc.subject.keywords | immunotherapy | - |
dc.subject.keywords | melanoma | - |
dc.subject.keywords | nephritis | - |
dc.subject.keywords | pneumonia | - |
dc.subject.keywords | seasonal variation | - |
dc.subject.keywords | immune checkpoint inhibitors | - |
dc.identifier.journaltitle | European Journal of Cancer | - |
dc.identifier.department | Oncology | - |
dc.contributor.wslhd | Pires da Silva, Ines | - |
dc.contributor.wslhd | Carlino, Matteo S. | - |
dc.type.studyortrial | Major Clinical Study | - |
dc.identifier.pmid | 38184928 | - |
dc.identifier.affiliation | Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia | - |
dc.identifier.affiliation | Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia | - |
dc.identifier.affiliation | Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland | - |
dc.identifier.affiliation | Faculty of Medicine, University of Zurich, Zurich, Switzerland | - |
dc.identifier.affiliation | Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom | - |
dc.identifier.affiliation | Charles Perkin Centre, The University of Sydney, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia | - |
dc.identifier.affiliation | Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia | - |
dc.identifier.affiliation | Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia | - |
dc.identifier.facility | Blacktown | - |
dc.identifier.facility | Westmead | - |
Appears in Collections: | Blacktown Mount Druitt Hospital |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.